 Ann-Christine Nyquist
Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 13 | 2024 | 625 | 1.900 |
Why?
| | Respiratory Tract Infections | 8 | 2021 | 396 | 1.100 |
Why?
| | Cross Infection | 7 | 2020 | 247 | 0.920 |
Why?
| | Infection Control | 4 | 2023 | 165 | 0.740 |
Why?
| | Surgical Wound Infection | 6 | 2023 | 310 | 0.700 |
Why?
| | Health Personnel | 9 | 2022 | 704 | 0.620 |
Why?
| | Bacteremia | 6 | 2019 | 211 | 0.480 |
Why?
| | Virus Diseases | 2 | 2016 | 214 | 0.480 |
Why?
| | Influenza Vaccines | 4 | 2024 | 539 | 0.480 |
Why?
| | Respiratory Protective Devices | 3 | 2021 | 14 | 0.470 |
Why?
| | Population Surveillance | 4 | 2020 | 473 | 0.400 |
Why?
| | Disease Outbreaks | 6 | 2020 | 384 | 0.390 |
Why?
| | Disaster Planning | 3 | 2020 | 89 | 0.380 |
Why?
| | Hospitals, Pediatric | 5 | 2019 | 533 | 0.370 |
Why?
| | Influenza A virus | 3 | 2014 | 110 | 0.360 |
Why?
| | Vaccination | 6 | 2024 | 1379 | 0.350 |
Why?
| | Influenza B virus | 2 | 2009 | 44 | 0.350 |
Why?
| | Chemical Terrorism | 2 | 2020 | 4 | 0.330 |
Why?
| | Bioterrorism | 2 | 2020 | 25 | 0.330 |
Why?
| | Disease Notification | 1 | 2009 | 16 | 0.320 |
Why?
| | Masks | 3 | 2021 | 63 | 0.320 |
Why?
| | Anti-Bacterial Agents | 4 | 2020 | 1805 | 0.300 |
Why?
| | Health Care Surveys | 1 | 2010 | 564 | 0.290 |
Why?
| | Equipment Contamination | 3 | 2019 | 63 | 0.270 |
Why?
| | Delivery of Health Care | 9 | 2022 | 944 | 0.260 |
Why?
| | Mycoplasma hominis | 1 | 2006 | 4 | 0.260 |
Why?
| | Endocarditis, Bacterial | 1 | 2006 | 42 | 0.250 |
Why?
| | Medication Systems, Hospital | 1 | 2005 | 9 | 0.250 |
Why?
| | Forms and Records Control | 1 | 2005 | 23 | 0.250 |
Why?
| | Enterovirus Infections | 3 | 2015 | 177 | 0.240 |
Why?
| | Drug Utilization Review | 1 | 2005 | 57 | 0.240 |
Why?
| | Electronics | 1 | 2005 | 75 | 0.240 |
Why?
| | Antibiotic Prophylaxis | 1 | 2005 | 117 | 0.230 |
Why?
| | Pandemics | 2 | 2022 | 1623 | 0.210 |
Why?
| | Humans | 47 | 2024 | 137294 | 0.210 |
Why?
| | Surgical Procedures, Operative | 1 | 2005 | 259 | 0.200 |
Why?
| | Seasons | 5 | 2024 | 545 | 0.190 |
Why?
| | Child | 19 | 2022 | 21999 | 0.190 |
Why?
| | Genes, Immediate-Early | 1 | 2002 | 21 | 0.190 |
Why?
| | Coronavirus OC43, Human | 1 | 2021 | 5 | 0.190 |
Why?
| | Tuberculosis, Spinal | 1 | 2001 | 8 | 0.190 |
Why?
| | Personal Protective Equipment | 1 | 2022 | 52 | 0.190 |
Why?
| | Genes, Viral | 1 | 2002 | 88 | 0.190 |
Why?
| | Meningitis, Viral | 2 | 2011 | 21 | 0.180 |
Why?
| | Thoracic Vertebrae | 1 | 2001 | 77 | 0.180 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2002 | 225 | 0.180 |
Why?
| | Orthomyxoviridae Infections | 1 | 2022 | 76 | 0.180 |
Why?
| | Physician's Role | 2 | 2020 | 210 | 0.180 |
Why?
| | Guideline Adherence | 1 | 2005 | 549 | 0.180 |
Why?
| | Virology | 2 | 2011 | 26 | 0.180 |
Why?
| | Cytomegalovirus | 1 | 2002 | 157 | 0.170 |
Why?
| | Colorado | 8 | 2020 | 4527 | 0.170 |
Why?
| | Hospitalization | 2 | 2015 | 2214 | 0.170 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2022 | 152 | 0.170 |
Why?
| | Enterovirus | 2 | 2011 | 86 | 0.170 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2002 | 202 | 0.170 |
Why?
| | Streptococcus pneumoniae | 3 | 2010 | 169 | 0.160 |
Why?
| | Civil Defense | 1 | 2020 | 19 | 0.160 |
Why?
| | Clostridium Infections | 1 | 2020 | 71 | 0.160 |
Why?
| | Practice Patterns, Physicians' | 2 | 1999 | 1302 | 0.160 |
Why?
| | Serratia Infections | 1 | 2019 | 7 | 0.160 |
Why?
| | Viruses | 1 | 2021 | 113 | 0.160 |
Why?
| | Infectious Disease Transmission, Patient-to-Professional | 1 | 2019 | 21 | 0.160 |
Why?
| | Serratia marcescens | 1 | 2019 | 18 | 0.160 |
Why?
| | Rotavirus Infections | 1 | 1999 | 43 | 0.160 |
Why?
| | Syringes | 1 | 2019 | 42 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 976 | 0.150 |
Why?
| | Heart Defects, Congenital | 1 | 2006 | 834 | 0.150 |
Why?
| | Antimicrobial Stewardship | 1 | 2020 | 117 | 0.150 |
Why?
| | Killer Cells, Natural | 1 | 2002 | 445 | 0.150 |
Why?
| | Pediatricians | 1 | 2020 | 129 | 0.150 |
Why?
| | Common Cold | 1 | 1998 | 13 | 0.140 |
Why?
| | Mandatory Programs | 1 | 2018 | 15 | 0.140 |
Why?
| | Child, Preschool | 11 | 2019 | 11080 | 0.140 |
Why?
| | Bronchitis | 1 | 1998 | 44 | 0.140 |
Why?
| | Social Participation | 1 | 2018 | 27 | 0.140 |
Why?
| | Communicable Diseases | 1 | 2020 | 160 | 0.140 |
Why?
| | Drug Utilization | 1 | 1998 | 170 | 0.130 |
Why?
| | Electronic Health Records | 2 | 2018 | 1045 | 0.130 |
Why?
| | United States | 13 | 2023 | 14742 | 0.130 |
Why?
| | Hospitals | 3 | 2023 | 689 | 0.130 |
Why?
| | Fatigue | 1 | 2018 | 328 | 0.130 |
Why?
| | Mutation | 1 | 2007 | 3956 | 0.120 |
Why?
| | Catheter-Related Infections | 1 | 2016 | 90 | 0.120 |
Why?
| | Spinal Fusion | 2 | 2013 | 251 | 0.120 |
Why?
| | Infant, Newborn | 5 | 2015 | 6054 | 0.120 |
Why?
| | Occupational Diseases | 1 | 2016 | 156 | 0.110 |
Why?
| | Herpesvirus 2, Human | 1 | 1994 | 29 | 0.110 |
Why?
| | Laryngeal Diseases | 1 | 1994 | 31 | 0.110 |
Why?
| | Gram-Positive Bacterial Infections | 2 | 2012 | 70 | 0.110 |
Why?
| | Adult | 11 | 2020 | 37724 | 0.110 |
Why?
| | Enterovirus D, Human | 1 | 2015 | 85 | 0.110 |
Why?
| | Acyclovir | 1 | 1994 | 101 | 0.110 |
Why?
| | Exercise Therapy | 1 | 2018 | 437 | 0.100 |
Why?
| | Herpes Simplex | 1 | 1994 | 95 | 0.100 |
Why?
| | Pertussis Vaccine | 1 | 2012 | 22 | 0.100 |
Why?
| | Shock | 1 | 2013 | 95 | 0.100 |
Why?
| | Bacillus cereus | 1 | 2012 | 5 | 0.100 |
Why?
| | Whooping Cough | 1 | 2012 | 51 | 0.100 |
Why?
| | Guidelines as Topic | 1 | 2014 | 278 | 0.090 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 323 | 0.090 |
Why?
| | Spinal Diseases | 1 | 2012 | 48 | 0.090 |
Why?
| | Age Distribution | 2 | 2010 | 391 | 0.090 |
Why?
| | Comorbidity | 1 | 2016 | 1624 | 0.090 |
Why?
| | Health Promotion | 1 | 2018 | 737 | 0.090 |
Why?
| | Adolescent | 9 | 2015 | 21499 | 0.090 |
Why?
| | Consensus | 3 | 2024 | 680 | 0.090 |
Why?
| | Shock, Septic | 1 | 2013 | 221 | 0.090 |
Why?
| | Decision Making | 1 | 2018 | 898 | 0.090 |
Why?
| | Infant | 8 | 2015 | 9451 | 0.090 |
Why?
| | Ethics, Clinical | 1 | 2010 | 7 | 0.090 |
Why?
| | Female | 18 | 2019 | 73052 | 0.080 |
Why?
| | Online Systems | 1 | 2010 | 22 | 0.080 |
Why?
| | Health Planning | 1 | 2010 | 47 | 0.080 |
Why?
| | Male | 16 | 2019 | 67560 | 0.080 |
Why?
| | Decontamination | 2 | 2020 | 30 | 0.080 |
Why?
| | Ethics, Medical | 1 | 2010 | 84 | 0.080 |
Why?
| | Laboratories, Hospital | 1 | 2009 | 15 | 0.080 |
Why?
| | Software | 1 | 2014 | 667 | 0.080 |
Why?
| | Orthopedic Procedures | 1 | 2012 | 221 | 0.080 |
Why?
| | Gonorrhea | 1 | 2010 | 59 | 0.080 |
Why?
| | Chlamydia Infections | 1 | 2010 | 74 | 0.080 |
Why?
| | Pneumococcal Infections | 1 | 2010 | 115 | 0.080 |
Why?
| | Poison Control Centers | 2 | 2020 | 90 | 0.080 |
Why?
| | Epoprostenol | 1 | 2009 | 136 | 0.080 |
Why?
| | Young Adult | 5 | 2015 | 13163 | 0.080 |
Why?
| | Workload | 1 | 2010 | 161 | 0.070 |
Why?
| | Clinical Laboratory Techniques | 1 | 2009 | 98 | 0.070 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 232 | 0.070 |
Why?
| | Catheterization, Central Venous | 1 | 2009 | 111 | 0.070 |
Why?
| | Genetic Drift | 1 | 2007 | 6 | 0.070 |
Why?
| | Prescriptions | 1 | 2008 | 67 | 0.070 |
Why?
| | Middle Aged | 7 | 2019 | 33310 | 0.070 |
Why?
| | Ethanol | 1 | 2012 | 608 | 0.070 |
Why?
| | Incidence | 4 | 2019 | 2808 | 0.070 |
Why?
| | Patient Care Team | 1 | 2012 | 629 | 0.070 |
Why?
| | Exercise | 1 | 2018 | 2045 | 0.060 |
Why?
| | Drug Resistance, Microbial | 2 | 1998 | 71 | 0.060 |
Why?
| | Respiratory System | 1 | 2007 | 157 | 0.060 |
Why?
| | Sexual Behavior | 1 | 2010 | 486 | 0.060 |
Why?
| | Antihypertensive Agents | 1 | 2009 | 488 | 0.060 |
Why?
| | Medical Audit | 1 | 2005 | 80 | 0.060 |
Why?
| | Internet | 1 | 2010 | 651 | 0.060 |
Why?
| | Pneumococcal Vaccines | 1 | 2006 | 142 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1577 | 0.060 |
Why?
| | Aged, 80 and over | 3 | 2015 | 7607 | 0.060 |
Why?
| | Risk Factors | 5 | 2021 | 10368 | 0.060 |
Why?
| | Program Evaluation | 3 | 2018 | 891 | 0.050 |
Why?
| | Ambulatory Care | 2 | 2019 | 539 | 0.050 |
Why?
| | Delphi Technique | 2 | 2016 | 274 | 0.050 |
Why?
| | Needs Assessment | 2 | 2020 | 373 | 0.050 |
Why?
| | Logistic Models | 3 | 2010 | 2071 | 0.050 |
Why?
| | Europe | 1 | 2024 | 414 | 0.050 |
Why?
| | Immunization Programs | 2 | 2018 | 213 | 0.050 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2022 | 38 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 1162 | 0.050 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2022 | 47 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2010 | 657 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2010 | 1521 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2010 | 5769 | 0.040 |
Why?
| | Pneumonia | 1 | 2006 | 640 | 0.040 |
Why?
| | Pediatrics | 2 | 2020 | 1113 | 0.040 |
Why?
| | Ricin | 1 | 2020 | 8 | 0.040 |
Why?
| | Containment of Biohazards | 1 | 2020 | 12 | 0.040 |
Why?
| | Smallpox | 1 | 2020 | 8 | 0.040 |
Why?
| | Nerve Agents | 1 | 2020 | 7 | 0.040 |
Why?
| | Government Agencies | 1 | 2020 | 17 | 0.040 |
Why?
| | Asphyxia | 1 | 2020 | 20 | 0.040 |
Why?
| | Surge Capacity | 1 | 2020 | 14 | 0.040 |
Why?
| | Biological Factors | 1 | 2020 | 39 | 0.040 |
Why?
| | Irritants | 1 | 2020 | 43 | 0.040 |
Why?
| | Government Regulation | 1 | 2020 | 54 | 0.040 |
Why?
| | Health Care Costs | 2 | 2013 | 387 | 0.040 |
Why?
| | Aged | 4 | 2015 | 23851 | 0.040 |
Why?
| | Transfection | 1 | 2002 | 947 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 260 | 0.040 |
Why?
| | Gait | 1 | 2001 | 297 | 0.040 |
Why?
| | Viral Vaccines | 1 | 1999 | 98 | 0.040 |
Why?
| | Anthropology, Cultural | 1 | 2018 | 22 | 0.040 |
Why?
| | Airway Obstruction | 1 | 2020 | 162 | 0.040 |
Why?
| | Health Services Misuse | 1 | 1998 | 34 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2009 | 1904 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2002 | 1184 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 624 | 0.040 |
Why?
| | Outpatients | 1 | 2021 | 394 | 0.030 |
Why?
| | Heparin | 1 | 2019 | 259 | 0.030 |
Why?
| | Histocompatibility Antigens Class II | 1 | 1999 | 368 | 0.030 |
Why?
| | Absenteeism | 1 | 2018 | 48 | 0.030 |
Why?
| | Rhinitis | 1 | 1999 | 158 | 0.030 |
Why?
| | Research | 1 | 2020 | 449 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2018 | 139 | 0.030 |
Why?
| | Nasopharyngeal Diseases | 1 | 1996 | 5 | 0.030 |
Why?
| | Fibroblasts | 1 | 2002 | 993 | 0.030 |
Why?
| | Lung Abscess | 1 | 1996 | 7 | 0.030 |
Why?
| | Streptococcus pyogenes | 1 | 1996 | 45 | 0.030 |
Why?
| | Illinois | 1 | 2015 | 43 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 61 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2019 | 338 | 0.030 |
Why?
| | Focus Groups | 1 | 2018 | 515 | 0.030 |
Why?
| | Environmental Exposure | 1 | 2020 | 577 | 0.030 |
Why?
| | Maryland | 1 | 2014 | 57 | 0.030 |
Why?
| | Respiratory Sounds | 1 | 2015 | 124 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2018 | 770 | 0.030 |
Why?
| | Cough | 1 | 2015 | 121 | 0.030 |
Why?
| | Health Policy | 1 | 2018 | 389 | 0.030 |
Why?
| | Foscarnet | 1 | 1994 | 19 | 0.030 |
Why?
| | Attitude to Health | 1 | 2018 | 440 | 0.030 |
Why?
| | Streptococcal Infections | 1 | 1996 | 151 | 0.030 |
Why?
| | Workplace | 1 | 2016 | 259 | 0.030 |
Why?
| | Fever | 1 | 2015 | 308 | 0.030 |
Why?
| | Dyspnea | 1 | 2015 | 252 | 0.030 |
Why?
| | Prevalence | 2 | 2010 | 2715 | 0.030 |
Why?
| | Public Health Surveillance | 1 | 2013 | 79 | 0.030 |
Why?
| | Mental Health | 1 | 2020 | 725 | 0.030 |
Why?
| | Prospective Studies | 2 | 2016 | 7595 | 0.030 |
Why?
| | Product Recalls and Withdrawals | 1 | 2012 | 2 | 0.020 |
Why?
| | Health Surveys | 1 | 2014 | 517 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2012 | 15639 | 0.020 |
Why?
| | Molecular Typing | 1 | 2012 | 22 | 0.020 |
Why?
| | Algorithms | 1 | 2020 | 1692 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2012 | 5125 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2015 | 643 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2010 | 3546 | 0.020 |
Why?
| | Qualitative Research | 1 | 2018 | 1367 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2012 | 180 | 0.020 |
Why?
| | Scoliosis | 1 | 2013 | 215 | 0.020 |
Why?
| | Critical Care | 1 | 2015 | 584 | 0.020 |
Why?
| | Cerebrospinal Fluid | 1 | 2010 | 94 | 0.020 |
Why?
| | San Francisco | 1 | 2010 | 52 | 0.020 |
Why?
| | Contact Tracing | 1 | 2010 | 26 | 0.020 |
Why?
| | Vaccines, Conjugate | 1 | 2010 | 65 | 0.020 |
Why?
| | Lung Diseases | 1 | 1996 | 769 | 0.020 |
Why?
| | Gram-Positive Bacteria | 1 | 2009 | 49 | 0.020 |
Why?
| | Sex Distribution | 1 | 2010 | 376 | 0.020 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2009 | 46 | 0.020 |
Why?
| | Gram-Negative Bacteria | 1 | 2009 | 75 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1484 | 0.020 |
Why?
| | Primary Health Care | 1 | 2020 | 1724 | 0.020 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 92 | 0.020 |
Why?
| | Reference Values | 1 | 2010 | 818 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2009 | 412 | 0.020 |
Why?
| | Risk Reduction Behavior | 1 | 2009 | 218 | 0.020 |
Why?
| | Sex Factors | 1 | 2013 | 2073 | 0.020 |
Why?
| | Urban Population | 1 | 2010 | 475 | 0.020 |
Why?
| | Serotyping | 1 | 2006 | 32 | 0.020 |
Why?
| | RNA, Viral | 1 | 2010 | 654 | 0.020 |
Why?
| | Length of Stay | 1 | 2012 | 1218 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3297 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2010 | 1946 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2010 | 1286 | 0.020 |
Why?
| | Immunization Schedule | 1 | 2006 | 197 | 0.010 |
Why?
| | Asthma | 1 | 2015 | 2293 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2010 | 1327 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6818 | 0.010 |
Why?
| | Gallium Radioisotopes | 1 | 1996 | 14 | 0.010 |
Why?
| | Retropharyngeal Abscess | 1 | 1996 | 7 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1996 | 118 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 1996 | 2679 | 0.000 |
Why?
|
|
Nyquist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|